LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: Natural Language Processing markers in first episode psychosis and people at clinical high-risk.

    Morgan, Sarah E / Diederen, Kelly / Vértes, Petra E / Ip, Samantha H Y / Wang, Bo / Thompson, Bethany / Demjaha, Arsime / De Micheli, Andrea / Oliver, Dominic / Liakata, Maria / Fusar-Poli, Paolo / Spencer, Tom J / McGuire, Philip

    Translational psychiatry

    2021  Volume 11, Issue 1, Page(s) 630

    Abstract: Recent work has suggested that disorganised speech might be a powerful predictor of later psychotic illness in clinical high risk subjects. To that end, several automated measures to quantify disorganisation of transcribed speech have been proposed. ... ...

    Abstract Recent work has suggested that disorganised speech might be a powerful predictor of later psychotic illness in clinical high risk subjects. To that end, several automated measures to quantify disorganisation of transcribed speech have been proposed. However, it remains unclear which measures are most strongly associated with psychosis, how different measures are related to each other and what the best strategies are to collect speech data from participants. Here, we assessed whether twelve automated Natural Language Processing markers could differentiate transcribed speech excerpts from subjects at clinical high risk for psychosis, first episode psychosis patients and healthy control subjects (total N = 54). In-line with previous work, several measures showed significant differences between groups, including semantic coherence, speech graph connectivity and a measure of whether speech was on-topic, the latter of which outperformed the related measure of tangentiality. Most NLP measures examined were only weakly related to each other, suggesting they provide complementary information. Finally, we compared the ability of transcribed speech generated using different tasks to differentiate the groups. Speech generated from picture descriptions of the Thematic Apperception Test and a story re-telling task outperformed free speech, suggesting that choice of speech generation method may be an important consideration. Overall, quantitative speech markers represent a promising direction for future clinical applications.
    MeSH term(s) Biomarkers ; Cognition ; Humans ; Natural Language Processing ; Psychotic Disorders/diagnosis ; Speech
    Chemical Substances Biomarkers
    Language English
    Publishing date 2021-12-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2609311-X
    ISSN 2158-3188 ; 2158-3188
    ISSN (online) 2158-3188
    ISSN 2158-3188
    DOI 10.1038/s41398-021-01722-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Ferritin exhibits Michaelis-Menten behavior with oxygen but not with iron during iron oxidation and core mineralization.

    Bou-Abdallah, Fadi / Flint, Nicholas / Wilkinson, Tyler / Salim, Samantha / Srivastava, Ayush Kumar / Poli, Maura / Arosio, Paolo / Melman, Artem

    Metallomics : integrated biometal science

    2019  Volume 11, Issue 4, Page(s) 774–783

    Abstract: The excessively high and inconsistent literature values for Km,Fe and Km,O2 prompted us to examine the iron oxidation kinetics in ferritin, the major iron storage protein in mammals, and to determine whether a traditional Michaelis-Menten enzymatic ... ...

    Abstract The excessively high and inconsistent literature values for Km,Fe and Km,O2 prompted us to examine the iron oxidation kinetics in ferritin, the major iron storage protein in mammals, and to determine whether a traditional Michaelis-Menten enzymatic behavior is obeyed. The kinetics of Fe(ii) oxidation and mineralization catalyzed by three different types of ferritins (recombinant human homopolymer 24H, HuHF, human heteropolymer ∼21H:3L, HL, and horse spleen heteropolymer ∼3.3H:20.7L, HosF) were therefore studied under physiologically relevant O2 concentrations, but also in the presence of excess Fe(ii) and O2 concentrations. The observed iron oxidation kinetics exhibited two distinct phases (phase I and phase II), neither of which obeyed Michaelis-Menten kinetics. While phase I was very rapid and corresponded to the oxidation of approximately 2 Fe(ii) ions per H-subunit, phase II was much slower and varied linearly with the concentration of iron(ii) cations in solution, independent of the size of the iron core. Under low oxygen concentration close to physiological, the iron uptake kinetics revealed a Michaelis-Menten behavior with Km,O2 values in the low μM range (i.e. ∼1-2 μM range). Our experimental Km,O2 values are significantly lower than typical cellular oxygen concentration, indicating that iron oxidation and mineralization in ferritin should not be affected by the oxygenation level of cells, and should proceed even under hypoxic events. A kinetic model is proposed in which the inhibition of the protein's activity is caused by bound iron(iii) cations at the ferroxidase center, with the rate limiting step corresponding to an exchange or a displacement reaction between incoming Fe(ii) cations and bound Fe(iii) cations.
    MeSH term(s) Animals ; Ferritins/metabolism ; Horses ; Humans ; Iron/metabolism ; Kinetics ; Oxidation-Reduction ; Oxygen/metabolism ; Recombinant Proteins/metabolism ; Spleen/metabolism
    Chemical Substances Recombinant Proteins ; Ferritins (9007-73-2) ; Iron (E1UOL152H7) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2019-03-07
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2474317-3
    ISSN 1756-591X ; 1756-5901
    ISSN (online) 1756-591X
    ISSN 1756-5901
    DOI 10.1039/c9mt00001a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Neutrophil gelatinase-associated lipocalin and acute kidney injury in endovascular aneurysm repair or open aortic repair: a pilot study.

    Rampoldi, Benedetta / Tessarolo, Serena / Giubbilini, Paola / Gaia, Paola / Corino, Samantha D / Mazza, Sarah / Rigolini, Roberta / Poli, Marco Dei / Vianello, Elena / Romanelli, Massimiliano M Corsi / Costa, Elena

    Biochemia medica

    2018  Volume 28, Issue 1, Page(s) 10904

    Abstract: Introduction: Acute kidney injury (AKI) occurs frequently after abdominal aortic surgery and there is currently no effective marker able to detect early onset. The aim of this study is to evaluate the ability of neutrophil gelatinase-associated ... ...

    Abstract Introduction: Acute kidney injury (AKI) occurs frequently after abdominal aortic surgery and there is currently no effective marker able to detect early onset. The aim of this study is to evaluate the ability of neutrophil gelatinase-associated lipocalin (NGAL) to early identify the development of acute renal damage in patients undergoing endovascular aneurysm repair (EVAR) or open aortic repair (OAR).
    Materials and methods: Serial samples of blood and urine were obtained from 25 patients undergoing both EVAR and OAR. Seven male subjects with AKI and 18 subjects with no-AKI (17 males, 1 female) were included in the study. We determined concentrations of serum creatinine (sCr) and urinary, serum and whole blood NGAL (uNGAL, sNGAL, bNGAL) collected at baseline, and after 4 and 18 hours. AKI was defined according to the RIFLE criteria (risk, injury, failure, loss of kidney function, and end-stage kidney disease): increase by 50% in sCr or reduction of at least 25% of estimated glomerular filtration rate (eGFR) from baseline.
    Results: Seven patients developed AKI in the stage Risk. There was no significant difference in sNGAL concentrations in the AKI group as compared to no-AKI group. However, the uNGAL/uCreatinine ratio and bNGAL concentrations were significantly higher after 18 hours in the AKI group (no-AKI 1.69 (0.91 - 2.47)
    Conclusions: Our results suggest that uNGAL, sNGAL and bNGAL, after abdominal aortic surgery, are not suitable as early biomarkers of AKI.
    MeSH term(s) Acute Kidney Injury/complications ; Acute Kidney Injury/diagnosis ; Area Under Curve ; Creatinine/blood ; Creatinine/urine ; Cross-Sectional Studies ; Endovascular Procedures/methods ; Female ; Humans ; Lipocalin-2/analysis ; Lipocalin-2/blood ; Lipocalin-2/urine ; Male ; Pilot Projects ; ROC Curve
    Chemical Substances Lipocalin-2 ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2018-01-10
    Publishing country Croatia
    Document type Journal Article
    ZDB-ID 1208725-7
    ISSN 1846-7482 ; 1330-0962
    ISSN (online) 1846-7482
    ISSN 1330-0962
    DOI 10.11613/BM.2018.010904
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.

    Villalba, Julian A / Hilburn, Caroline F / Garlin, Michelle A / Elliott, Grant A / Li, Yijia / Kunitoki, Keiko / Poli, Sergio / Alba, George A / Madrigal, Emilio / Taso, Manuel / Price, Melissa C / Aviles, Alexis J / Araujo-Medina, Milagros / Bonanno, Liana / Boyraz, Baris / Champion, Samantha N / Harris, Cynthia K / Helland, Timothy L / Hutchison, Bailey /
    Jobbagy, Soma / Marshall, Michael S / Shepherd, Daniel J / Barth, Jaimie L / Hung, Yin P / Ly, Amy / Hariri, Lida P / Turbett, Sarah E / Pierce, Virginia M / Branda, John A / Rosenberg, Eric S / Mendez-Pena, Javier / Chebib, Ivan / Rosales, Ivy A / Smith, Rex N / Miller, Miles A / Rosas, Ivan O / Hardin, Charles C / Baden, Lindsey R / Medoff, Benjamin D / Colvin, Robert B / Little, Brent P / Stone, James R / Mino-Kenudson, Mari / Shih, Angela R

    American journal of respiratory and critical care medicine

    2021  Volume 206, Issue 7, Page(s) 857–873

    Abstract: Rationale: ...

    Abstract Rationale:
    MeSH term(s) COVID-19/complications ; Humans ; Lung/diagnostic imaging ; Lung/pathology ; Pneumonia ; Pulmonary Alveoli/pathology ; Respiratory Distress Syndrome/etiology ; Vascular Diseases
    Language English
    Publishing date 2021-10-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202109-2150OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.

    Marson, Bernardo P / Lacchini, Riccardo / Belo, Vanessa / Dickel, Samantha / da Costa, Bartira P / Poli de Figueiredo, Carlos E / Tanus-Santos, Jose E

    American journal of nephrology

    2012  Volume 35, Issue 3, Page(s) 209–215

    Abstract: Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are implicated in the vascular ... ...

    Abstract Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are implicated in the vascular alterations of end-stage kidney disease (ESKD) patients. We have examined whether MMP-2 gene polymorphisms and haplotypes modify MMP-2 and TIMP-2 levels in ESKD patients as well as the effects of hemodialysis on the concentrations of these biomarkers.
    Methods: We determined MMP-2 and TIMP-2 plasma levels by gelatin zymography and ELISA, respectively, in 98 ESKD patients and in 38 healthy controls. Genotypes for two relevant MMP-2 polymorphisms (C(-1306)T and C(-735)T in the promoter region) were determined by TaqMan(®) allele discrimination assay and real-time polymerase chain reaction. The software program PHASE 2.1 was used to estimate the haplotype frequencies.
    Results: We found increased plasma MMP-2 and TIMP-2 levels in ESKD patients compared to controls (p < 0.05), and hemodialysis decreased MMP-2 (but not TIMP-2) levels (p < 0.05). The T allele for the C(-735)T polymorphism and the C-T haplotype were associated with higher MMP-2 (but not TIMP-2) levels (p < 0.05), whereas the C(-1306)T had no effects. Hemodialysis decreased MMP-2 (but not TIMP-2) levels independently of MMP-2 genotypes or haplotypes (p < 0.05).
    Conclusions: MMP-2 genotypes or haplotypes modify MMP-2 levels in ESKD patients, and may help to identify patients with increased MMP-2 activity in plasma. Hemodialysis reduces MMP-2 levels independently of MMP-2 genetic variants.
    MeSH term(s) Adult ; Biomarkers ; Case-Control Studies ; Cross-Sectional Studies ; Female ; Genotype ; Haplotypes ; Humans ; Kidney Failure, Chronic/blood ; Kidney Failure, Chronic/genetics ; Kidney Failure, Chronic/metabolism ; Male ; Matrix Metalloproteinase 2/blood ; Matrix Metalloproteinase 2/genetics ; Matrix Metalloproteinase 2/metabolism ; Middle Aged ; Polymorphism, Genetic ; Renal Dialysis ; Tissue Inhibitor of Metalloproteinase-2/blood ; Tissue Inhibitor of Metalloproteinase-2/metabolism
    Chemical Substances Biomarkers ; TIMP2 protein, human ; Tissue Inhibitor of Metalloproteinase-2 (127497-59-0) ; MMP2 protein, human (EC 3.4.24.24) ; Matrix Metalloproteinase 2 (EC 3.4.24.24)
    Language English
    Publishing date 2012
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604540-6
    ISSN 1421-9670 ; 0250-8095
    ISSN (online) 1421-9670
    ISSN 0250-8095
    DOI 10.1159/000336108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Prediction of atrial fibrillation from surface ECG: review of methods and algorithms.

    Poli, Samantha / Barbaro, Vincenzo / Bartolini, Pietro / Calcagnini, Giovanni / Censi, Federica

    Annali dell'Istituto superiore di sanita

    2003  Volume 39, Issue 2, Page(s) 195–203

    Abstract: The study aims to review the mathematical methods developed for the prediction of atrial fibrillation by analysis of surface electrocardiographic records in paroxysmal or post-cardiosurgery patients. A risk stratification based on ECG analysis would be ... ...

    Abstract The study aims to review the mathematical methods developed for the prediction of atrial fibrillation by analysis of surface electrocardiographic records in paroxysmal or post-cardiosurgery patients. A risk stratification based on ECG analysis would be very useful either to optimise the prophylactic antiarrhythmic treatment in high risk patients, or to limit drugs administration in low risk subjects. The works published so far managed to achieve good results in terms of sensitivity and specificity. However, since these methods are not completely reliable yet, their clinical application is still limited. The present study is divided in sections about time domain, frequency domain, premature complexes detection, heart rate variability, and non linear ECG analysis based methods.
    MeSH term(s) Algorithms ; Anti-Arrhythmia Agents/therapeutic use ; Atrial Fibrillation/physiopathology ; Atrial Fibrillation/prevention & control ; Atrial Premature Complexes/diagnosis ; Atrial Premature Complexes/physiopathology ; Cardiac Surgical Procedures ; Electrocardiography/methods ; Electrocardiography/statistics & numerical data ; Heart Rate ; Humans ; Postoperative Complications/physiopathology ; Postoperative Complications/prevention & control ; Predictive Value of Tests ; Risk Assessment ; Sensitivity and Specificity
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2003
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 950344-4
    ISSN 0021-2571
    ISSN 0021-2571
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Adherences on antihypertensive treatments in patients with systemic hypertension in a health unit

    Marli Maria Loro, Thiely Samantha Kitzmann, Cleci Schmidt Rosanelli, Adriane Cristina Bernat Kolankiewicz, Gilmar Poli

    Revista de Enfermagem UFPE On Line, Vol 4, Iss 4, Pp 1600-

    2010  Volume 1608

    Abstract: Objective: to identify how adherences occur on antihypertensive treatments in patients with Systemic Hypertension in a Family Health’s strategy Unit, in a northwestern city of Rio Grande Do Sul state. Methodology: qualitative study from descriptive. The ... ...

    Abstract Objective: to identify how adherences occur on antihypertensive treatments in patients with Systemic Hypertension in a Family Health’s strategy Unit, in a northwestern city of Rio Grande Do Sul state. Methodology: qualitative study from descriptive. The sample consists of 13 individuals identified by health professionals of the health service. Data collection was through interviews and data were analyzed in light of the content analysis, resulting in a subject of analysis. Ethical aspects were respected recommended by Resolution 196/96, and was approved by the Ethics in Research UNIJUI, on the advice embodied 0153/2008. Results: the depositions yielded a topic of analysis called antihypertensive treatment adherences, which deals about concerning aspects of the understanding HAS patients in respect to adherence treatment needs, because being a pathology, occasionally silent, the carrier has to take active stance in his treatment witch involves drug therapy instead of just drugs. On the research was identified that the individual level of educational instructions didn’t influence on treatment adherence. Conclusion: it is necessary that the subject implement changes in the lifestyle to guarantee the blood pressure controls. Descriptors: hypertension; patient acceptance of health care; therapeutics; health unit; patients; educational status; life style.
    Keywords hypertension ; patient acceptance of health care ; therapeutics ; health unit ; patients ; educational status ; life style ; Nursing ; RT1-120 ; Medicine ; R ; DOAJ:Nursing ; DOAJ:Health Sciences
    Language Portuguese
    Publishing date 2010-10-01T00:00:00Z
    Publisher Universidade Federal de Pernambuco
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease

    Marson, Bernardo P. / Lacchini, Riccardo / Belo, Vanessa / Dickel, Samantha / da Costa, Bartira P. / Poli de Figueiredo, Carlos E. / Tanus-Santos, Jose E.

    American Journal of Nephrology

    2012  Volume 35, Issue 3, Page(s) 209–215

    Abstract: Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are implicated in the vascular ... ...

    Institution Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, and Faculty of Medicine/IPB/HSL of Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
    Abstract Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are implicated in the vascular alterations of end-stage kidney disease (ESKD) patients. We have examined whether MMP-2 gene polymorphisms and haplotypes modify MMP-2 and TIMP-2 levels in ESKD patients as well as the effects of hemodialysis on the concentrations of these biomarkers. Methods: We determined MMP-2 and TIMP-2 plasma levels by gelatin zymography and ELISA, respectively, in 98 ESKD patients and in 38 healthy controls. Genotypes for two relevant MMP-2 polymorphisms (C–1306T and C–735T in the promoter region) were determined by TaqMan® allele discrimination assay and real-time polymerase chain reaction. The software program PHASE 2.1 was used to estimate the haplotype frequencies. Results: We found increased plasma MMP-2 and TIMP-2 levels in ESKD patients compared to controls (p < 0.05), and hemodialysis decreased MMP-2 (but not TIMP-2) levels (p < 0.05). The T allele for the C–735T polymorphism and the C-T haplotype were associated with higher MMP-2 (but not TIMP-2) levels (p < 0.05), whereas the C–1306T had no effects. Hemodialysis decreased MMP-2 (but not TIMP-2) levels independently of MMP-2 genotypes or haplotypes (p < 0.05). Conclusions: MMP-2 genotypes or haplotypes modify MMP-2 levels in ESKD patients, and may help to identify patients with increased MMP-2 activity in plasma. Hemodialysis reduces MMP-2 levels independently of MMP-2 genetic variants.
    Keywords End-stage kidney disease ; Haplotypes ; Hemodialysis ; Matrix metalloproteinase-2 ; Polymorphisms ; Tissue inhibitor of metalloproteinases-2
    Language English
    Publishing date 2012-02-01
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Original Report: Patient-Oriented, Translational Research
    ZDB-ID 604540-6
    ISSN 1421-9670 ; 0250-8095
    ISSN (online) 1421-9670
    ISSN 0250-8095
    DOI 10.1159/000336108
    Database Karger publisher's database

    More links

    Kategorien

  9. Article ; Online: Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease.

    Marson, Bernardo P / Dickel, Samantha / Ishizawa, Marília H / Metzger, Ingrid F / Izidoro-Toledo, Tatiane / da Costa, Bartira Ercília Pinheiro / Poli-de-Figueiredo, Carlos E / Tanus-Santos, Jose E

    DNA and cell biology

    2011  Volume 30, Issue 1, Page(s) 55–59

    Abstract: The identification of genetic markers associated with chronic kidney disease (CKD) may help to predict its development. Because reduced nitric oxide (NO) bioavailability and endothelial dysfunction are involved in CKD, genetic polymorphisms in the gene ... ...

    Abstract The identification of genetic markers associated with chronic kidney disease (CKD) may help to predict its development. Because reduced nitric oxide (NO) bioavailability and endothelial dysfunction are involved in CKD, genetic polymorphisms in the gene encoding the enzyme involved in NO synthesis (endothelial NO synthase [eNos]) may affect the susceptibility to CKD and the development of end-stage renal disease (ESRD). We compared genotype and haplotype distributions of three relevant eNOS polymorphisms (T(-786)C in the promoter region, Glu298Asp in exon 7, and 4b/4a in intron 4) in 110 healthy control subjects and 127 ESRD patients. Genotypes for the T(-786)C and Glu298Asp polymorphisms were determined by TaqMan(®) Allele Discrimination assay and real-time polymerase chain reaction. Genotypes for the intron 4 polymorphism were determined by polymerase chain reaction and fragment separation by electrophoresis. The software program PHASE 2.1 was used to estimate the haplotypes frequencies. We considered significant a probability value of p < 0.05/number of haplotypes (p < 0.05/8 = 0.0063). We found no significant differences between groups with respect to age, ethnicity, and gender. CKD patients had higher blood pressure, total cholesterol, and creatinine levels than healthy control subjects (all p < 0.05). Genotype and allele distributions for the three eNOS polymorphisms were similar in both groups (p > 0.05). We found no significant differences in haplotype distribution between groups (p > 0.05). The lack of significant associations between eNOS polymorphisms and ESRD suggests that eNOS polymorphisms may not be relevant to the genetic component of CKD that leads to ESRD.
    MeSH term(s) Adult ; Case-Control Studies ; Female ; Gene Frequency ; Genetic Markers/genetics ; Haplotypes ; Humans ; Kidney Failure, Chronic/enzymology ; Kidney Failure, Chronic/genetics ; Male ; Nitric Oxide Synthase Type III/genetics ; Polymorphism, Single Nucleotide
    Chemical Substances Genetic Markers ; Nitric Oxide Synthase Type III (EC 1.14.13.39)
    Language English
    Publishing date 2011-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1024454-2
    ISSN 1557-7430 ; 0198-0238 ; 1044-5498
    ISSN (online) 1557-7430
    ISSN 0198-0238 ; 1044-5498
    DOI 10.1089/dna.2010.1106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

    Wannan, Cassandra M J / Nelson, Barnaby / Addington, Jean / Allott, Kelly / Anticevic, Alan / Arango, Celso / Baker, Justin T / Bearden, Carrie E / Billah, Tashrif / Bouix, Sylvain / Broome, Matthew R / Buccilli, Kate / Cadenhead, Kristin S / Calkins, Monica E / Cannon, Tyrone D / Cecci, Guillermo / Chen, Eric Yu Hai / Cho, Kang Ik K / Choi, Jimmy /
    Clark, Scott R / Coleman, Michael J / Conus, Philippe / Corcoran, Cheryl M / Cornblatt, Barbara A / Diaz-Caneja, Covadonga M / Dwyer, Dominic / Ebdrup, Bjørn H / Ellman, Lauren M / Fusar-Poli, Paolo / Galindo, Liliana / Gaspar, Pablo A / Gerber, Carla / Glenthøj, Louise Birkedal / Glynn, Robert / Harms, Michael P / Horton, Leslie E / Kahn, René S / Kambeitz, Joseph / Kambeitz-Ilankovic, Lana / Kane, John M / Kapur, Tina / Keshavan, Matcheri S / Kim, Sung-Wan / Koutsouleris, Nikolaos / Kubicki, Marek / Kwon, Jun Soo / Langbein, Kerstin / Lewandowski, Kathryn E / Light, Gregory A / Mamah, Daniel / Marcy, Patricia J / Mathalon, Daniel H / McGorry, Patrick D / Mittal, Vijay A / Nordentoft, Merete / Nunez, Angela / Pasternak, Ofer / Pearlson, Godfrey D / Perez, Jesus / Perkins, Diana O / Powers, Albert R / Roalf, David R / Sabb, Fred W / Schiffman, Jason / Shah, Jai L / Smesny, Stefan / Spark, Jessica / Stone, William S / Strauss, Gregory P / Tamayo, Zailyn / Torous, John / Upthegrove, Rachel / Vangel, Mark / Verma, Swapna / Wang, Jijun / Rossum, Inge Winter-van / Wolf, Daniel H / Wolff, Phillip / Wood, Stephen J / Yung, Alison R / Agurto, Carla / Alvarez-Jimenez, Mario / Amminger, Paul / Armando, Marco / Asgari-Targhi, Ameneh / Cahill, John / Carrión, Ricardo E / Castro, Eduardo / Cetin-Karayumak, Suheyla / Mallar Chakravarty, M / Cho, Youngsun T / Cotter, David / D'Alfonso, Simon / Ennis, Michaela / Fadnavis, Shreyas / Fonteneau, Clara / Gao, Caroline / Gupta, Tina / Gur, Raquel E / Gur, Ruben C / Hamilton, Holly K / Hoftman, Gil D / Jacobs, Grace R / Jarcho, Johanna / Ji, Jie Lisa / Kohler, Christian G / Lalousis, Paris Alexandros / Lavoie, Suzie / Lepage, Martin / Liebenthal, Einat / Mervis, Josh / Murty, Vishnu / Nicholas, Spero C / Ning, Lipeng / Penzel, Nora / Poldrack, Russell / Polosecki, Pablo / Pratt, Danielle N / Rabin, Rachel / Rahimi Eichi, Habiballah / Rathi, Yogesh / Reichenberg, Avraham / Reinen, Jenna / Rogers, Jack / Ruiz-Yu, Bernalyn / Scott, Isabelle / Seitz-Holland, Johanna / Srihari, Vinod H / Srivastava, Agrima / Thompson, Andrew / Turetsky, Bruce I / Walsh, Barbara C / Whitford, Thomas / Wigman, Johanna T W / Yao, Beier / Yuen, Hok Pan / Ahmed, Uzair / Byun, Andrew Jin Soo / Chung, Yoonho / Do, Kim / Hendricks, Larry / Huynh, Kevin / Jeffries, Clark / Lane, Erlend / Langholm, Carsten / Lin, Eric / Mantua, Valentina / Santorelli, Gennarina / Ruparel, Kosha / Zoupou, Eirini / Adasme, Tatiana / Addamo, Lauren / Adery, Laura / Ali, Munaza / Auther, Andrea / Aversa, Samantha / Baek, Seon-Hwa / Bates, Kelly / Bathery, Alyssa / Bayer, Johanna M M / Beedham, Rebecca / Bilgrami, Zarina / Birch, Sonia / Bonoldi, Ilaria / Borders, Owen / Borgatti, Renato / Brown, Lisa / Bruna, Alejandro / Carrington, Holly / Castillo-Passi, Rolando I / Chen, Justine / Cheng, Nicholas / Ching, Ann Ee / Clifford, Chloe / Colton, Beau-Luke / Contreras, Pamela / Corral, Sebastián / Damiani, Stefano / Done, Monica / Estradé, Andrés / Etuka, Brandon Asika / Formica, Melanie / Furlan, Rachel / Geljic, Mia / Germano, Carmela / Getachew, Ruth / Goncalves, Mathias / Haidar, Anastasia / Hartmann, Jessica / Jo, Anna / John, Omar / Kerins, Sarah / Kerr, Melissa / Kesselring, Irena / Kim, Honey / Kim, Nicholas / Kinney, Kyle / Krcmar, Marija / Kotler, Elana / Lafanechere, Melanie / Lee, Clarice / Llerena, Joshua / Markiewicz, Christopher / Matnejl, Priya / Maturana, Alejandro / Mavambu, Aissata / Mayol-Troncoso, Rocío / McDonnell, Amelia / McGowan, Alessia / McLaughlin, Danielle / McIlhenny, Rebecca / McQueen, Brittany / Mebrahtu, Yohannes / Mensi, Martina / Hui, Christy Lai Ming / Suen, Yi Nam / Wong, Stephanie Ming Yin / Morrell, Neal / Omar, Mariam / Partridge, Alice / Phassouliotis, Christina / Pichiecchio, Anna / Politi, Pierluigi / Porter, Christian / Provenzani, Umberto / Prunier, Nicholas / Raj, Jasmine / Ray, Susan / Rayner, Victoria / Reyes, Manuel / Reynolds, Kate / Rush, Sage / Salinas, Cesar / Shetty, Jashmina / Snowball, Callum / Tod, Sophie / Turra-Fariña, Gabriel / Valle, Daniela / Veale, Simone / Whitson, Sarah / Wickham, Alana / Youn, Sarah / Zamorano, Francisco / Zavaglia, Elissa / Zinberg, Jamie / Woods, Scott W / Shenton, Martha E

    Schizophrenia bulletin

    2024  Volume 50, Issue 3, Page(s) 496–512

    Abstract: This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict trajectories and outcomes of ... ...

    Abstract This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the development and use of novel pharmacological interventions for CHR individuals. We present a description of the participating research networks and the data processing analysis and coordination center, their processes for data harmonization across 43 sites from 13 participating countries (recruitment across North America, Australia, Europe, Asia, and South America), data flow and quality assessment processes, data analyses, and the transfer of data to the National Institute of Mental Health (NIMH) Data Archive (NDA) for use by the research community. In an expected sample of approximately 2000 CHR individuals and 640 matched healthy controls, AMP SCZ will collect clinical, environmental, and cognitive data along with multimodal biomarkers, including neuroimaging, electrophysiology, fluid biospecimens, speech and facial expression samples, novel measures derived from digital health technologies including smartphone-based daily surveys, and passive sensing as well as actigraphy. The study will investigate a range of clinical outcomes over a 2-year period, including transition to psychosis, remission or persistence of CHR status, attenuated positive symptoms, persistent negative symptoms, mood and anxiety symptoms, and psychosocial functioning. The global reach of AMP SCZ and its harmonized innovative methods promise to catalyze the development of new treatments to address critical unmet clinical and public health needs in CHR individuals.
    MeSH term(s) Humans ; Psychotic Disorders ; Schizophrenia ; Prospective Studies ; Adult ; Prodromal Symptoms ; Young Adult ; International Cooperation ; Adolescent ; Research Design/standards ; Male ; Female
    Language English
    Publishing date 2024-03-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 439173-1
    ISSN 1745-1701 ; 0586-7614
    ISSN (online) 1745-1701
    ISSN 0586-7614
    DOI 10.1093/schbul/sbae011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top